1 / 12

Key messages

Key messages. Stephen S Lim, et al. Lancet 2007; 370: 2054-62. Countries that account for 80% of global chronic disease deaths in low-income and middle-income countries. Stephen S Lim, et al. Lancet 2007; 370: 2054-62. Main model parameters. Stephen S Lim, et al. Lancet 2007; 370: 2054-62.

aida
Download Presentation

Key messages

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Key messages Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  2. Countries that account for 80% of global chronic disease deaths in low-income and middle-income countries Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  3. Main model parameters Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  4. Example of an absolute risk chart using age, sex, smoking status, systolic blood pressure, and body-mass index *Numbers are 10-year risk of fatal ischaemic heart disease or cardiovascular events in Mexico Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  5. Patterns of scale-up of a multidrug regimen for patients at high risk of cardiovascular disease by Commission on Macroeconomics in Health (CMH) category, expressed as a proportion of those accessing health services Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  6. Effects of diff erent individual drugs, measured as relative risk, on fatal and non-fatal ischaemic heart disease and cerebrovascular disease Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  7. Patient cost parameters Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  8. Cumulative thousands of deaths averted with a multidrug regimen for the prevention of cardiovascular disease by sex, 2006-15 Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  9. Person-years of treatment and number of deaths averted by age and sex, 2006-15 Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  10. Cumulative financial cost of scaling up a multidrug regimen for the prevention of cardiovascular disease, 2006-15 Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  11. Average yearly cost (US$ per head) of scaling up a multidrug regimen for the prevention of cardiovascular disease by country, 2006-15 Stephen S Lim, et al. Lancet 2007; 370: 2054-62

  12. Average yearly cost (proportion of current health expenditure) of scaling up a multidrug regimen for the prevention of cardiovascular disease by country, 2006-15 Stephen S Lim, et al. Lancet 2007; 370: 2054-62

More Related